7ROO image
Entry Detail
PDB ID:
7ROO
Keywords:
Title:
Crystal structure of Friedel-Crafts alkylating enzyme CylK from Cylindospermum licheniforme with bromide
Biological Source:
PDB Version:
Deposition Date:
2021-07-31
Release Date:
2022-03-23
Method Details:
Experimental Method:
Resolution:
1.52 Å
R-Value Free:
0.19
R-Value Work:
0.16
R-Value Observed:
0.17
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:CylK
Chain IDs:A
Chain Length:686
Number of Molecules:1
Biological Source:Cylindrospermum licheniforme UTEX B 2014
Primary Citation
Structural basis for an unprecedented enzymatic alkylation in cylindrocyclophane biosynthesis.
Elife 11 ? ? (2022)
PMID: 35212625 DOI: 10.7554/eLife.75761

Abstact

The cyanobacterial enzyme CylK assembles the cylindrocyclophane natural products by performing two unusual alkylation reactions, forming new carbon-carbon bonds between aromatic rings and secondary alkyl halide substrates. This transformation is unprecedented in biology, and the structure and mechanism of CylK are unknown. Here, we report X-ray crystal structures of CylK, revealing a distinctive fusion of a Ca2+-binding domain and a β-propeller fold. We use a mutagenic screening approach to locate CylK's active site at its domain interface, identifying two residues, Arg105 and Tyr473, that are required for catalysis. Anomalous diffraction datasets collected with bound bromide ions, a product analog, suggest that these residues interact with the alkyl halide electrophile. Additional mutagenesis and molecular dynamics simulations implicate Asp440 in activating the nucleophilic aromatic ring. Bioinformatic analysis of CylK homologs from other cyanobacteria establishes that they conserve these key catalytic amino acids, but they are likely associated with divergent reactivity and altered secondary metabolism. By gaining a molecular understanding of this unusual biosynthetic transformation, this work fills a gap in our understanding of how alkyl halides are activated and used by enzymes as biosynthetic intermediates, informing enzyme engineering, catalyst design, and natural product discovery.

Legend

Protein

Chemical

Disease

Primary Citation of related structures